Active, Not Recruiting Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV NCT04514484 Conditions Adenocarcinoma, Adnexal Diseases, Advanced Differentiated Thyroid Gland Carcinoma, +141 more Locations Northwestern University — Chicago, Illinois, United States Montefiore Medical Center-Einstein Campus — The Bronx, New York, United States University of Pittsburgh Cancer Institute (UPCI) — Pittsburgh, Pennsylvania, United States View Trial Details
Active, Not Recruiting Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer NCT03941730 Conditions Advanced Triple-Negative Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, +9 more Locations University of Alabama at Birmingham Cancer Center — Birmingham, Alabama, United States UCSF Medical Center-Mission Bay — San Francisco, California, United States MedStar Georgetown University Hospital — Washington D.C., District of Columbia, United States Mayo Clinic in Florida — Jacksonville, Florida, United States View more locations Show fewer locations Loading locations... View Trial Details
